El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic software solutions, announced that Children’s Hospital of Los Angeles (CHLA), an award-winning hospital with comprehensive medical care services and programs for children, has signed on as a BioDiscovery Center of Excellence for Clinical Genomics to serve as a reference site for others seeking information […]
COLUMBUS, Ohio–As concerns about Americans’ exposure to a certain group of chemical substances continues to grow, Battelle researchers have added another tool in their suite to help assess and understand occurrence. Known as per- and polyfluoroalkyl substances (PFAS), PFAS are chemicals that have been used for decades in products that repel stains, water, grease, and oil and in firefighting […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution to support its innovative oncology pipeline, including investigational product programs for Debio 0123 (Selective WEE1 inhibitor), diagnostic molecular screening for […]
Today the ultra-high-throughput genetic sequencer, DNBSEQ-T7, independently developed by Shenzhen’s MGI Tech Co., Ltd. (MGI), was officially delivered to business partners. The first sequencers have arrived at the joint labs of partners such as BGI Tech Solutions Co., Ltd. and WeGene. Pre-delivery user test data showed that T7 performed well according to all indicators. As […]
Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered non-small cell lung cancer and thyroid cancer patients who may be suitable for LOXO-292, Lilly’s RET inhibitor CARLSBAD, Calif. — Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S […]
OAKLAND, Calif.–Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced […]
ANN ARBOR, Mich. – Swift Biosciences announced the launch of its Swift RNA Library Kits today. Leveraging the company’s innovative and patented Adaptase® technology, the Swift RNA Library Kits allow direct conversion of first-strand complementary DNA (cDNA), reverse transcribed from RNA, into high-quality libraries for Illumina® sequencing. Swift is entering the RNA-Seq market with two kits, the […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announces the release of a new high-throughput integrated fluidic circuit (HT IFC) to isolate single cells for mRNA sequencing analysis. Capturing up to 800 medium-size (10-17 µm) cells with higher single-cell capture efficiency, the new medium-cell HT IFC enables researchers to confidently scale cell atlasing and lineage studies […]
AACHEN, Germany At genomics-online.com, researchers can locate and purchase millions of genomics and transcriptomics research reagents like: Primers and probes for DNA amplification, sequencing, & qPCR CRISPR/Cas9 gene editing vectors and primers A wide selection of cloning and expression vectors Restriction endonucleases, DNA & RNA polymerases and other enzymes DNA & RNA isolation and extraction […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company continues reinforcing the foundation for long-term growth. Jonathan will join Illumina on January 3, 2017. Jonathan Seaton “Jonathan is a strong leader with an established track […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
